Wnt signalling and its impact on development and cancer
By Alexandra Klaus, W. Birchmeier. Nature Reviews. Cancer, 2008
1,602 citations recorded by the source corpus.
Subfields: Molecular Biology
View Paper: https://www.semanticscholar.org/paper/f44135d951fd87faeee70c1507ead99072ee3b14
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Biology
Citations in the corpus
- β-Catenin hits chromatin: regulation of Wnt target gene activation (2009, background): “This complex consists of axin , the adenomatous polyposis coli ( APC ) tumour suppressor protein, glycogen synthase kinase 3β ( GSK3β ), casein kinase 1 ( CK1 ) and protein phosphatase 2A ( PP2A”
- Dietary (Poly)phenolics in Human Health: Structures, Bioavailability, and Evidence of Protective Effects Against Chronic Diseases (2013, neutral): “Investigating this pathway is extremely relevant as Wnt proteins are a family of highly conserved, secreted signaling molecules playing a pivotal role in cellular development and carcinogenesis, with a large percentage (*90%) of colon cancers arising from activating mutations in the Wnt pathway (250”
- WNT/TCF signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasis (2009, background): “2006; Klaus and Birchmeier, 2008; Logan and Nusse, 2004; Moon et al., 2004).”
- Senescence-messaging secretome: SMS-ing cellular stress (2009, background): “Despite the existence of these functional connections, it is as yet unclear to what extent these in vitro findings, and also the dominant role of Wnt signalling in tumorigenesi”
- The Metabolic Profile of Tumors Depends on both the Responsible Genetic Lesion and Tissue Type (2012, background): “…and Kinzler, 2004), are well-known regulators of cellular metabolism (reviewed in (Yuneva, 2008); b-catenin, a central player in the Wnt pathway (Klaus and Birchmeier, 2008), regulates genes responsible for glutamine synthesis (Cadoret et al., 2002); and b-catenin activation in mouse liver is…”
- Targeting MET in cancer: rationale and progress (2012, background): “Mutation or overexpression of key components of the WNT–β-catenin pathway can cause cance”
- Exosomes in Cancer Development, Metastasis and Drug Resistance: A Comprehensive Review (2013, neutral): “Wnt signaling plays central role in tissue development, and aberrations in this evolutionary conserved pathway has been shown to be linked with the development of cancers [183].”
- Interplay of cadherin-mediated cell adhesion and canonical Wnt signaling. (2010, background): “The Wnt/b-catenin signaling pathway has a crucial role in the embryonic development of all animal species, in the regeneration of tissues in adult organisms and in numerous other processes (reviewed by Cadigan and Nusse 1997; Clevers 2006; Klaus and Birchmeier 2008).”
- Mucins in cancer: function, prognosis and therapy (2009, background): “MUC1 thereby integrates the disruption of adherens junctions with the activation of the Wnt pathway, which has been linked to growth and tumorigenesi”
- Covalent histone modifications: miswritten, misinterpreted, and miserased in human cancers (2010, background): “Mutations in components of the Wnt–β-catenin pathway lead to oncogenesis in several tissue type”
- Wnt signaling in cancer. (2012, background): “Ultimately, the TCF transcription factors that associated with b-catenin completed the understanding of a basic signaling pathway that could account for the potent tumori- genic effects of Wnt (reviewed by Klaus and Birchmeier 2008).”